Literature DB >> 17996602

Characteristics of ductal carcinoma in situ in magnetic resonance imaging.

Mirjam Facius1, Diane M Renz, Henning Neubauer, Joachim Böttcher, Mieczyslaw Gajda, Oumar Camara, Werner A Kaiser.   

Abstract

PURPOSE: The aim of this study was to evaluate typical dynamic and morphological characteristics of ductal carcinoma in situ (DCIS) in magnetic resonance imaging (MRI). An optimized diagnosis of DCIS is considered to be valuable for radiologists and clinicians, especially for early and successful treatment planning.
MATERIALS AND METHODS: Magnetic resonance examinations of 74 patients with pure DCIS were evaluated. Categories were established for signal increase (C1=the same enhancement as glandular tissue; C2=slow and continuous; C3=strong initial and slow further increase; C4=strong initial increase and plateau phenomenon; and C5=strong initial increase followed by a washout phenomenon) and morphological findings (M0=no pattern observed; M1=linear or linear-branched; M2=segmental dotted or granular; M3=segmental homogenous; and M4=focal spotlike). All cases were associated with histopathological results.
RESULTS: Regarding the 74 DCIS lesions, 37 (50%) showed a signal increase typical of malignancy (C4 and C5). Among all cases, 33.3% of G1 lesions, 68.4% of G2 lesions, and 55.5% of G3 lesions presented a C4 or C5 enhancement. Furthermore, 55.4% (n=41) showed a segmental dotted enhancement (M2), whereas 17.6% showed a focal spotlike enhancement (M4). The morphological features of the other lesions were as follows: 12.2% homogeneous (M3) and 4.0% linear (M1). In 8 cases (10.8%), no significant pattern was observed (M0). Combining dynamic and morphological characteristics, 68.9% presented an appearance comparable with the appearance of invasive breast cancer in MRI.
CONCLUSIONS: Ductal CIS lesions show typical morphological and kinetic, but heterogeneous, characteristics in MRI, comparable with the histopathological variety of the disease. For detecting pure DCIS cases early and precisely, a combination of dynamic and morphological criteria seems to be important.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996602     DOI: 10.1016/j.clinimag.2007.04.030

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  12 in total

1.  MRI of the breast in patients with DCIS to exclude the presence of invasive disease.

Authors:  Eline E Deurloo; Jincey D Sriram; Hendrik J Teertstra; Claudette E Loo; Jelle Wesseling; Emiel J Th Rutgers; Kenneth G A Gilhuijs
Journal:  Eur Radiol       Date:  2012-02-26       Impact factor: 5.315

2.  Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.

Authors:  Anna M Chiarelli; Kristina M Blackmore; Derek Muradali; Susan J Done; Vicky Majpruz; Ashini Weerasinghe; Lucia Mirea; Andrea Eisen; Linda Rabeneck; Ellen Warner
Journal:  J Natl Cancer Inst       Date:  2020-02-01       Impact factor: 13.506

3.  Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters.

Authors:  Naoko Mori; Hideki Ota; Shunji Mugikura; Chiaki Takasawa; Junya Tominaga; Takanori Ishida; Mika Watanabe; Kei Takase; Shoki Takahashi
Journal:  Eur Radiol       Date:  2013-06-04       Impact factor: 5.315

4.  The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy.

Authors:  Mariko Goto; Sachiko Yuen; Kentaro Akazawa; Kaori Nishida; Eiichi Konishi; Mariko Kajihara; Nobuhiko Shinkura; Kei Yamada
Journal:  Eur Radiol       Date:  2011-12-30       Impact factor: 5.315

5.  In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.

Authors:  Habib Rahbar; Savannah C Partridge; Wendy B Demartini; Robert L Gutierrez; Kimberly H Allison; Sue Peacock; Constance D Lehman
Journal:  Radiology       Date:  2012-05       Impact factor: 11.105

6.  Differentiation of ductal carcinoma in-situ from benign micro-calcifications by dedicated breast computed tomography.

Authors:  Shadi Aminololama-Shakeri; Craig K Abbey; Peymon Gazi; Nicolas D Prionas; Anita Nosratieh; Chin-Shang Li; John M Boone; Karen K Lindfors
Journal:  Eur J Radiol       Date:  2015-10-01       Impact factor: 3.528

7.  Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Naoko Mori; Hiroyuki Abe; Shunji Mugikura; Minoru Miyashita; Yu Mori; Yo Oguma; Minami Hirasawa; Satoko Sato; Kei Takase
Journal:  Breast Cancer       Date:  2021-04-26       Impact factor: 4.239

8.  Differentiation between Clinically Noninflammatory Granulomatous Lobular Mastitis and Noncalcified Ductal Carcinoma in situ Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Authors:  Ning Qu; Yahong Luo; Tao Yu
Journal:  Breast Care (Basel)       Date:  2020-02-25       Impact factor: 2.860

9.  Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features?

Authors:  Siwa Chan; Jeon-Hor Chen; Garima Agrawal; Muqing Lin; Rita S Mehta; Philip M Carpenter; Orhan Nalcioglu; Min-Ying Su
Journal:  J Oncol       Date:  2010-09-21       Impact factor: 4.375

10.  Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement.

Authors:  Dustin Newell; Ke Nie; Jeon-Hor Chen; Chieh-Chih Hsu; Hon J Yu; Orhan Nalcioglu; Min-Ying Su
Journal:  Eur Radiol       Date:  2009-09-30       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.